Vyome Holdings, Inc. Share Price
NASDAQ: HIND | Micro CapVyome Holdings, Inc. Stock Performance
Vyome Holdings, Inc. Share Price Chart
Vyome Holdings, Inc. Quarterly Profit & Loss
All figures in USD
Vyome Holdings, Inc. Annual Profit & Loss
All figures in USD
About Vyome Holdings, Inc.
Vyome Holdings Inc is a clinical-stage specialty pharmaceutical company working to treat immune-inflammatory and rare diseases of unmet need with next-generation therapeutic solutions. Its product candidates are: VT-1953, a topical gel that is being developed to treat signs and symptoms of malignant fungating wounds in cancer; VT-1908, a repurposed immune modulator to treat steroid-sparing anterior uveitis; and VB1953, which is being developed to treat moderate to severe acne. Vyome has also commercialized two novel reformulated topical anti-fungal products based on the technology platform of Molecular Replacement Therapeutics (MRT) in India: a dandruff lotion and shampoo. It operates in two segments: pharmaceutical products, which generate the maximum revenue, and biotechnology.
Vyome Holdings, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $1.92 | $2.03 | +6.23% |
Sep 2026 | $2.17 | $1.91 | -15.49% |
Aug 2026 | $2.18 | $2.26 | +7.62% |
Jul 2026 | $2.24 | $2.10 | -5.41% |
Jun 2026 | $2.33 | $2.22 | -6.33% |
May 2026 | $2.07 | $2.37 | +8.72% |
Apr 2026 | $2.26 | $2.18 | +2.83% |
Mar 2026 | $3.33 | $2.12 | -37.28% |
Feb 2026 | $1.89 | $3.38 | +78.36% |
Jan 2026 | $3.49 | $1.90 | -44.91% |
Dec 2025 | $5.13 | $3.44 | -23.73% |
Nov 2025 | $6.30 | $4.51 | -24.33% |
HIND Share Price FAQs
What is Vyome Holdings, Inc. share price today?
What is the 52 week high and 52 week low of Vyome Holdings, Inc. stock?
What is HIND's market capitalisation today?
What is HIND's net income for the last quarter?
What is the 5 year returns of HIND?
What is the high & low stock price of HIND today?
Can I buy HIND shares in India?